On route to chimeric antigen receptor t-cell (car t) therapy, less is more: adaptive bridging radiotherapy in large b-cell lymphoma

HIGHLIGHTS

• What: This approach has been effective in achieving local tumor control without amplifying the toxicities of CAR T-cell therapy infusion .
• Who: (CAR T) Therapy and colleagues from the Radiation, General Hospital, Harvard Medical School, Boston, USA have published the Article: Review began 07/17/2024 Review ended 08/18/2024 Published 08/23/2024 © Copyright, in the Journal: (JOURNAL) of August/23,/2024
• How: Adaptive treatment timing analysis A timing analysis was performed for the four online adaptive sessions and the results are shown in Table 2.

SUMMARY

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.